The Weekly Recap 6/5/26: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni receive new funding, receive regulatory approvals, achieve clinical milestones, and much more on the road to LSI Asia ‘26 in Singapore (June 30 - July 2).

Advanced NanoTherapies

Closed an oversubscribed Series B financing totaling more than $31M, co-led by an undisclosed strategic investor and S3 Ventures, with participation from the T45 Fund and new and existing investors. ANT aims to redefine the vascular intervention paradigm with a next-generation dual-drug (paclitaxel and sirolimus) nanoparticle on a percutaneous balloon platform.

CorWave

Secured ISO 13485 certification across its entire operations, covering the design, development, manufacturing, distribution, and servicing of implantable left ventricular assist devices (LVADs). The certification demonstrates compliance with the medical device industry’s internationally recognized quality management standard and supports the company’s progress toward its pivotal trial and future commercialization.

FineHeart

Welcomed Pierre Chauvineau to its Board of Directors. Chauvineau has more than 35 years of international leadership experience in the medtech industry and brings extensive expertise in scaling innovative companies, driving global market expansion, and successfully translating breakthrough technologies into clinical and commercial success.

Jean Nehme

Launched morph., a physically intelligent soft robotics platform that designs and manufactures soft robotic cells. The company also announced that it received investment from 8VC, Pharrell Williams, Copper, Harvey Spevak, Chairman of Equinox Group, Qubit Health Capital, Valia Ventures, and Blue Lion. 

Lungpacer Medical

Welcomed Steven Pfanstiel as CFO. Pfanstiel brings nearly 25 years of financial and operational leadership across the medtech industry, including prior CFO roles at Neuronetics and Marinus Pharmaceuticals, where he helped guide a commercial launch and sale of the company to Immedica Pharma.

Nephrodite

Selected to the FDA Total Product Life Cycle Advisory Program (TAP) for its investigational Holly™ implantable continuous dialysis system. Holly is an implantable, continuous dialysis system designed to provide sustained toxin clearance and fluid balance without the burden of intermittent, clinic-based dialysis.

Nina Capital

Welcomed Lily Chen as a Medtech Advisor and Limited Partner. Chen brings a wealth of knowledge in building clinical evidence, KOL advocacy, and driving international commercialization and hospital access across EMEA, APAC, and the Americas.

Noah Medical

Appointed Dr. Krish Bhadra as Chief Pulmonary Advisor. Dr. Bhadra brings deep clinical expertise and a distinguished track record of innovation in lung cancer diagnosis and treatment.

Omniscient Neurotechnology (o8t)

Closed a $27.2M oversubscribed Series D funding round co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation (NRFC), with continued support from long-term investors including Will Vicars and Gina Rinehart AO. The capital will accelerate the commercial expansion of Omniscient's Quicktome^® platform and the development of new clinical applications, extending the company's reach into high-growth markets like BCI, stroke, and movement disorders.

Petal Surgical

Announced a new financing led by Blue Pool Capital, with participation from Salience Capital, A&E Investments, TIME Ventures, and existing investors including Actions Capital (formerly K50 Ventures). The financing follows continued preclinical progress as the company advances its incisionless surgery platform toward first-in-human studies.

Prana Surgical

Appointed LSI Alumni Natasha Bond as COO. Bond brings 30 years of experience in the medical device industry and has deep expertise in the commercialization and regulatory approval of novel technologies across interventional pulmonology, neurology, peripheral vascular, and cardiology.

Precision Cardiovascular

Appointed LSI Alumni Brian Fahey, Ph.D., to its Board of Directors as an independent director. Dr. Fahey is a seasoned medical technology executive, founder, and board director who brings strong technical depth, strategic judgment, and operational leadership, particularly in highly regulated Class III implantable device markets.

SamanTree Medical

Welcomed Ben Hennessy as VP International Indirect Markets, bringing more than 20 years of experience in medical technology, working with both large-cap corporations and startup medical device companies. The company also welcomed Dr. Tina Manoharan as Chief Digital & AI Officer, bringing more than 20 years of experience advancing precision diagnostics through Digital Pathology, Radiology, and AI.

UltraSight

Published new peer-reviewed data in the European Heart Journal – Digital Health, highlighting the potential of AI-guided cardiac ultrasound to help expand access to imaging across healthcare settings. The multicenter study showed that novice operators with no prior ultrasound experience achieved diagnostic-quality cardiac ultrasound images in 97.7% of cases after just one day of AI-guided training.

Veritas Aortic Solutions

Closed a $12M Seed financing round, led by a group of experienced medtech angel investors with strong participation from Cedars-Sinai Intellectual Property Company, along with inQB8's existing investors. The funds will support the continued development of the Veritas Transcatheter Valved Aortic Root Conduit (TVARC), a comprehensive, interventional, non-surgical treatment for high-risk Root and Ascending Aortic Diseases, including Dissections, Aneurysms, and other pathologies that specifically involve the aortic root, coronary ostia, and/or the ascending aorta.

Zepto Life Technology

Received FDA BDD for its FungiFlex^® Mold Panel. The FungiFlex Mold Panel is a targeted liquid biopsy test designed to aid diagnosis through the detection and identification of fungal cell-free DNA directly from plasma, providing organism-level information early in the diagnostic journey.

Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.